List of All Articles with Tag 'h'

The Bank of England is the last of the big central banks to meet before the summer break

Thirty-six officials in South Korea are under investigation for failing to prevent the tragedy.

Global bonds took another leg lower after the Bank of Japan signaled it will allow yields to climb

AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the

People living with hepatitis B (HBV) and hepatitis C (HCV) could be just as likely or more likely to develop cancer than someone smoking a pack of cigarettes a day, new research suggests. According to the Center for Disease Analysis (CDA) Foundation, people infected with hepatitis B and C viruses “have a similar or significantly higher risk of developing cancer than someone who actively smokes one pack of cigarettes per day”, and therefore HBC and HBC should be “considered as cancer causing infections and international guidelines should be reconsidered accordingly”. Hepatitis is the term used to describe inflammation of the liver, according to the NHS. Hepatitis B is spread in the blood of an infected person – it can be spread from infected women to their babies, or through unprotected sex and injecting drugs – and hepatitis C is usually spread through blood-to-blood contact with an infected person. The NHS says HCV is most commonly spread in the UK through sharing needles used to inject drugs. The foundation found that HBV and HCV viruses are highly oncogenic. Oncogenes are mutated genes which can lead to cancers in multiple organs and sites. Homie Razavi, managing director at CDA Foundation said: “Hepatitis B and C infections are silent epidemics. These viral infections are cancer causing but since infected individuals don’t show any symptoms until it is too late, most infections go unnoticed. “It is important for all of us to recognise the high risk of cancer associated with hepatitis B and C infections and get patients linked to care. Treatment can reduce the risk of cancer by 85% or more.” As part of a call on World Hepatitis Day 2023 (July 28), the World Hepatitis Alliance (WHA) has launched a campaign called ‘We’re not waiting’ with its global network of 323 members in over 100 countries, in order speed up the fight against the disease, which claims a life every 30 seconds. In a new survey, the WHA found that 42% of people around the world are unaware that viral hepatitis is one of the leading causes of liver cancer. Nearly three-quarters (74%) of those surveyed said knowing that hepatitis causes liver cancer means they are more likely to get tested, whilst 82% would get vaccinated. In total, over 350 million people have been diagnosed with either hepatitis B or C around the world, which results in more than 1.1 million deaths every year. And by 2024, deaths caused by this disease could surpass mortality from malaria, HIV, and tuberculosis combined, according to the WHA. “Every year, more than a million lives are lost to hepatitis,” said Danjuma Adda, president of the WHA. “The theme of World Hepatitis Day 2023 is ‘We’re not waiting’. It’s a call to accelerate elimination efforts of viral hepatitis now and the urgent need for testing and treatment for the real people who need it. “Individuals and communities around the world are making change happen in their own lives and in [the] world around them. We celebrate them, while demanding more action. We’re not waiting for change – we’re fighting to make it happen.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

Oil headed for the longest run of weekly gains in more than a year on an improving macroeconomic

Banco Bilbao Vizcaya Argentaria SA reported earnings that beat estimates and said it would buy back as much

On a September night in California aboard the superyacht “Aviva,” one of the UK’s richest men sat down

Consumer goods giant Unilever said on Friday it has appointed Ian Meakins as its chair designate, replacing current

China’s domestic tourism market is expected to rebound to 90% of pre-pandemic levels this year thanks to surging

By Joe Cash BEIJING China's factory activity likely contracted for a fourth straight month in July, a Reuters

Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent